Mostly Markets
Subscribe
Stocks/Materials/Specialty Chemicals

AlbemarleALB

Specialty Chemicals · Charlotte, North Carolina · In the S&P 500
Solid businessCheaper than peers
$91.00−2.43%After hours: $91.06 (+0.07%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 7.0% over 1 year
Albemarle over 1 yearDaily close, $, to 30 Oct 2026
$100$150$200Nov2026MarMayJulSep$91.00$150$200NovMarJul$91.00
Source: Nasdaq daily closes
Market value$10.74B
Price to earnings–
Forward P/E9.2x
Dividend yield1.80%
Year to date−35.7%
One year−7.0%
Next earningsWed 4 Nov, after the close
SectorMaterials
52-week range (closes)
$88.45$215.62

Quality and valuation

How Albemarle compares with other materials stocks. A description, not a recommendation.

Albemarle and 5 specialty chemicals peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: cheaper than most

An average business among materials companies, priced below most of them.

Albemarle trades at 9.2 times the next 12 months of expected earnings, against a median of 16.1x for the 28 materials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +18.3% vs +9.1%
  • Keeps less of each sale (gross margin): 23.8% vs 27.9%
  • Less profitable (operating margin): 4.3% vs 10.9%
  • Turns more of its sales into cash: 22.7% vs 7.6%
ALB trades at 9.2x forward earnings, below the sector medianForward p/e, Specialty Chemicals peers
ALB9.2xLYB9.4xPPG14.7xSHW26.6xIFF27.2xECL35.5xSector median 16.1xALB9.2xLYB9.4xPPG14.7xSHW26.6xIFF27.2xECL35.5xSector median 16.1x
Source: CNBC quotes; Mostly Markets

Financials

From Albemarle's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 31.1% from a year earlierQuarterly revenue, $bn, latest Q2 ’26
$0.0bn$0.5bn$1.0bn$1.5bnQ3 ’24Q1 ’25Q3 ’25$1.7bnQ2 ’26$0bn$1bnQ3 ’24Q1 ’25Q3 ’25$1.7bnQ2 ’26
Source: SEC filings
Growth slowed to +31.1% last quarterRevenue growth, year on year, %
−25%0%25%Q3 ’24Q1 ’25Q3 ’2531.1%Q2 ’260%Q3 ’24Q1 ’25Q3 ’2531.1%Q2 ’26
Source: SEC filings
Operating margin was 26.0% last quarterOperating income as a share of revenue, %
−50%0%Q3 ’24Q1 ’25Q3 ’2526.0%Q2 ’26−50%0%Q3 ’24Q1 ’25Q3 ’2526.0%Q2 ’26
Source: SEC filings
Free cash flow was $1.3 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
−$250m$0m$250m$500mQ3 ’24Q1 ’25Q3 ’25$638mQ2 ’26$0m$500mQ3 ’24Q1 ’25Q3 ’25$638mQ2 ’26
Source: SEC filings
Last 12 monthsALBSector median
Revenue growth+18.3%+9.1%
Gross margin23.8%27.9%
Operating margin4.3%10.9%
Free cash flow margin22.7%7.6%

Stories on Albemarle

We haven't written about Albemarle yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Specialty Chemicals, by market value.

CompanyPriceTodayYTDValue
ECLEcolab$302.98+0.70%+15.4%$84.93B
SHWSherwin-Williams$332.61+0.76%+2.6%$80.36B
PPGPPG Industries$119.52−0.40%+16.7%$26.40B
IFFInternational Flavors & Fragrances$93.02+2.43%+38.0%$23.73B
LYBLyondellBasell$68.64+5.00%+58.5%$22.17B